The inflammatory response to cardiopulmonary bypass

[1]  R. Bartlett,et al.  A heparin-coated circuit reduces complement activation and the release of leukocyte inflammatory mediators during extracorporeal circulation in a rabbit. , 2008, Artificial organs.

[2]  S. Thelin,et al.  Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. , 2008, Artificial organs.

[3]  K M Taylor,et al.  The platelet in cardiopulmonary bypass. , 1998, The Annals of thoracic surgery.

[4]  K. Taylor,et al.  Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. , 1998, The Annals of thoracic surgery.

[5]  A. Siegbahn,et al.  Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. , 1997, The Journal of thoracic and cardiovascular surgery.

[6]  P. Toft,et al.  The role of cytokines in cardiac surgery. , 1996, International journal of cardiology.

[7]  J. Bion,et al.  Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. , 1996, JAMA.

[8]  H. O. Oudemans-van Straaten,et al.  Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor. , 1995, The Journal of thoracic and cardiovascular surgery.

[9]  J. Maessen,et al.  Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass. , 1995, The Journal of thoracic and cardiovascular surgery.

[10]  E. Fosse,et al.  Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. , 1995, The Journal of thoracic and cardiovascular surgery.

[11]  G. Hill,et al.  Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. , 1995, The Journal of thoracic and cardiovascular surgery.

[12]  T. Ino,et al.  Interleukin-8 and monocyte chemotactic activating factor responses to cardiopulmonary bypass. , 1995, The Journal of thoracic and cardiovascular surgery.

[13]  M. Tönz,et al.  The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study. , 1995, The Journal of thoracic and cardiovascular surgery.

[14]  W. Greeley,et al.  Hemofiltration during Cardiopulmonary Bypass in Pediatric Cardiac Surgery: Effects on Hemostasis, Cytokines, and Complement Components , 1994, Anesthesiology.

[15]  M. Dehoux,et al.  Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.

[16]  L. Greenfield,et al.  Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. , 1994, The Journal of thoracic and cardiovascular surgery.

[17]  E. Fosse,et al.  Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.

[18]  G. Hill,et al.  Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humans. , 1994, Anesthesia and analgesia.

[19]  G. von Bernuth,et al.  Complement, leukocytes, and leukocyte elastase in full-term neonates undergoing cardiac operation. , 1994, The Journal of thoracic and cardiovascular surgery.

[20]  B. Risberg,et al.  Hemofiltration modifies complement activation after extracorporeal circulation in infants. , 1993, The Annals of thoracic surgery.

[21]  R. Linhardt,et al.  Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. , 1993, Blood.

[22]  M. Elliott,et al.  Ultrafiltration and modified ultrafiltration in pediatric open heart operations. , 1993, The Annals of thoracic surgery.

[23]  G. von Bernuth,et al.  Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. , 1993, The Journal of thoracic and cardiovascular surgery.

[24]  J. Weiler,et al.  Cytokine and complement levels in patients undergoing cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.

[25]  R. Wakusawa,et al.  Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[26]  J. Levy,et al.  Inflammation and cardiopulmonary bypass , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[27]  K. Matsushima,et al.  Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8 , 1993, Nature.

[28]  W. Baumgartner,et al.  Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators. , 1993, The Annals of thoracic surgery.

[29]  L. Bossaert,et al.  Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. , 1993, The American review of respiratory disease.

[30]  R. Colman,et al.  Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. , 1993, The Journal of thoracic and cardiovascular surgery.

[31]  C. Dinarello,et al.  Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. , 1993, JAMA.

[32]  J. M. Lipton,et al.  Perioperative measurements of interleukin-6 and alpha-melanocyte-stimulating hormone in cardiac transplant patients. , 1993, Journal of cardiothoracic and vascular anesthesia.

[33]  S Westaby,et al.  Inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[34]  M. Elliott,et al.  Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.

[35]  L. Cohn,et al.  Complete prevention of myocardial stunning, contracture, low-reflow, and edema after heart transplantation by blocking neutrophil adhesion molecules during reperfusion , 1992 .

[36]  G. Weissmann,et al.  A Mechanism for the Antiinflammatory Effects of Corticosteroids , 1993, Journal of Pediatric Gastroenterology and Nutrition.

[37]  W. van Oeveren,et al.  Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. , 1992, The Annals of thoracic surgery.

[38]  T. Standiford,et al.  Anoxia-hyperoxia induces monocyte-derived interleukin-8. , 1992, The Journal of clinical investigation.

[39]  J. M. Lipton,et al.  DOES APROTININ INHIBIT CARDIOPULMONARY BYPASSINDUCED INFLAMMATION , 1992 .

[40]  P. Cooper.  Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.

[41]  J. Gaer,et al.  Intraabdominal complications after cardiopulmonary bypass. , 1991, The Annals of thoracic surgery.

[42]  M. Oppermann,et al.  Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin. , 1991, The Annals of thoracic surgery.

[43]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  V. Videm,et al.  Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits. , 1991, The Journal of thoracic and cardiovascular surgery.

[45]  F. Sebening,et al.  Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. , 1990, Anesthesiology.

[46]  D. Noonan,et al.  C5a-mediated release of interleukin 6 by human monocytes. , 1990, Clinical immunology and immunopathology.

[47]  L. Kulander,et al.  Endotoxins in cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[48]  C. Dinarello,et al.  Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. , 1990, Blood.

[49]  R. Cotran,et al.  The role of endothelial cells in inflammation. , 1990, Transplantation.

[50]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[51]  W. Fraser,et al.  Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. , 1990, Clinical science.

[52]  L. Osborn,et al.  Leukocyte adhesion to endothelium in inflammation , 1990, Cell.

[53]  W. van Oeveren,et al.  Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[54]  M. Arnaout,et al.  Structure and function of the leukocyte adhesion molecules CD11/CD18 , 1990 .

[55]  P. Libby,et al.  Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. , 1990, The Journal of clinical investigation.

[56]  Rodger P. McEver,et al.  Rapid neutrophil adhesion to activated endothelium mediated by GMP-140 , 1990, Nature.

[57]  J. Cavaillon,et al.  Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide‐stimulated monocytes and macrophages , 1990, European journal of immunology.

[58]  A. Carpentier,et al.  Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. , 1989, The Journal of thoracic and cardiovascular surgery.

[59]  I. von Zabern,et al.  Non-enzymic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product, C5b-like C5. , 1989, Molecular immunology.

[60]  D. Wagner,et al.  PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes , 1989, Cell.

[61]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.

[62]  I. Ginsburg,et al.  Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. , 1989, The American journal of pathology.

[63]  L. W. Andersen,et al.  Endotoxemia and enhanced generation of oxygen radicals by neutrophils from patients undergoing cardiopulmonary bypass. , 1989, The Journal of thoracic and cardiovascular surgery.

[64]  G. Schreiner,et al.  Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[65]  T. Kishimoto,et al.  The biology of interleukin-6. , 1989, Blood.

[66]  P. Sims,et al.  Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. , 1989, The Journal of biological chemistry.

[67]  Michael Loran Dustin,et al.  Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1 , 1989, Nature.

[68]  N. Hogg.  The leukocyte integrins. , 1989, Immunology today.

[69]  R. Cook,et al.  Cloning of GMP-140, a granule membrane protein of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and inflammation , 1989, Cell.

[70]  B. Seed,et al.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. , 1989, Science.

[71]  D. Cosgrove,et al.  Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.

[72]  R. Howard,et al.  Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation. , 1988, Archives of surgery.

[73]  J. Pober.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. , 1988, The American journal of pathology.

[74]  S. Ogoshi,et al.  Complement activation in cardiopulmonary bypass, with special reference to anaphylatoxin production in membrane and bubble oxygenators. , 1988, The Annals of thoracic surgery.

[75]  C. Dinarello,et al.  C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha , 1988, The Journal of experimental medicine.

[76]  S. Khuri,et al.  The Effects of Complement Activation During Cardiopulmonary Bypass: Attenuation by Hypothermia, Heparin, and Hemodilution , 1988, Annals of surgery.

[77]  W. Hörl,et al.  Plasma levels of main granulocyte components during cardiopulmonary bypass. , 1988, The Journal of thoracic and cardiovascular surgery.

[78]  S. Clark,et al.  Multiple actions of interleukin 6 within a cytokine network. , 1988, Immunology today.

[79]  B. Seed,et al.  ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM , 1988, Nature.

[80]  K. M. Taylor,et al.  EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY , 1987, The Lancet.

[81]  C. Hack,et al.  SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSES , 1987, The Lancet.

[82]  C. Dinarello,et al.  C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma. , 1987, Journal of immunology.

[83]  J. Cavaillon,et al.  C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. , 1987, Journal of immunology.

[84]  S. Gaffin,et al.  Endotoxemia associated with cardiopulmonary bypass. , 1987, The Journal of thoracic and cardiovascular surgery.

[85]  Richard O. Hynes,et al.  Integrins: A family of cell surface receptors , 1987, Cell.

[86]  B. Beutler,et al.  Cachectin: more than a tumor necrosis factor. , 1987, The New England journal of medicine.

[87]  H. Colten,et al.  Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. , 1986, The Journal of clinical investigation.

[88]  A. Marty,et al.  Anaphylactic Reactions in Anesthesia and Intensive Care , 1986 .

[89]  W. W. Bailey,et al.  The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass. , 1986, Surgery.

[90]  J. Gamble,et al.  Stimulation of neutrophils by tumor necrosis factor. , 1986, Journal of immunology.

[91]  R. Colman,et al.  Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. , 1986, Blood.

[92]  J. Fleming,et al.  Increased production of peroxidation products associated with cardiac operations. Evidence for free radical generation. , 1986, The Journal of thoracic and cardiovascular surgery.

[93]  G. Deeb,et al.  Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators. , 1986, The Journal of thoracic and cardiovascular surgery.

[94]  E. Blackstone,et al.  Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. , 1986, The Annals of thoracic surgery.

[95]  H. Schaff,et al.  Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass. , 1985, Surgery.

[96]  J. Hogg,et al.  The effect of body temperature on leukocyte kinetics during cardiopulmonary bypass. , 1985, The Journal of thoracic and cardiovascular surgery.

[97]  A. Carpentier,et al.  Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. , 1985, The Journal of thoracic and cardiovascular surgery.

[98]  C. Dang,et al.  Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D. , 1985, Science.

[99]  H. Verbrugh,et al.  Cardiopulmonary bypass and host defense functions in human beings: I. Serum levels and role of immunoglobulins and complement in phagocytosis. , 1985, The Annals of thoracic surgery.

[100]  J. Harlan.  Leukocyte-endothelial interactions. , 1985, Blood.

[101]  D. Magilligan.  Indications for ultrafiltration in the cardiac surgical patient. , 1985, The Journal of thoracic and cardiovascular surgery.

[102]  C. Dollery,et al.  Dexamethasone inhibits the production of thromboxane B2 and leukotriene B4 by human alveolar and peritoneal macrophages in culture. , 1984, Clinical science.

[103]  C. Dinarello.  Interleukin-1 and the pathogenesis of the acute-phase response. , 1984, The New England journal of medicine.

[104]  D. Vergani,et al.  Pathways to complement activation during cardiopulmonary bypass. , 1984 .

[105]  P. Henson,et al.  Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro. , 1984, The Journal of clinical investigation.

[106]  S Westaby,et al.  Complement and the damaging effects of cardiopulmonary bypass. , 1983, The Journal of thoracic and cardiovascular surgery.

[107]  R. Colman,et al.  Human plasma kallikrein releases neutrophil elastase during blood coagulation. , 1983, The Journal of clinical investigation.

[108]  F. Zaimi,et al.  Perioperative changes in complement associated with cardiopulmonary bypass. , 1982, British journal of anaesthesia.

[109]  R. Colman,et al.  Purified human plasma kallikrein aggregates human blood neutrophils. , 1982, The Journal of clinical investigation.

[110]  W. Rating,et al.  Effects of Dexamethason on the Early Postoperative Course after Coronary Artery Bypass Surgery , 1982, The Thoracic and cardiovascular surgeon.

[111]  H. Jacob,et al.  Complement-induced granulocyte aggregation in vivo. , 1981, The American journal of pathology.

[112]  E. Blackstone,et al.  Intracardiac surgery in infants under age 3 months: incremental risk factors for hospital mortality. , 1981, The American journal of cardiology.

[113]  E. Townsend,et al.  Pulmonary Dysfunction Associated with Cardiopulmonary Bypass: A Comparison of Bubble and Membrane Oxygenators , 1981, Circulation.

[114]  White Jv.  Complement activation during cardiopulmonary bypass. , 1981 .

[115]  S. Dahlén,et al.  Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[116]  E. Blackstone,et al.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. , 1981, The New England journal of medicine.

[117]  M. J. Moore,et al.  Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. , 1980, The New England journal of medicine.

[118]  L. Joyce,et al.  Effects of Glucocorticosteriods in Patients Undergoing Coronary Artery Bypass Surgery , 1979 .

[119]  R. Byrick,et al.  Postperfusion lung syndrome. Comparison of Travenol bubble and membrane oxygenators. , 1978, The Journal of thoracic and cardiovascular surgery.

[120]  T. Hugli,et al.  Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[121]  H. Jacob,et al.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. , 1978, The Journal of clinical investigation.

[122]  J. White,et al.  Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. , 1977, The Journal of clinical investigation.

[123]  G. Machiedo,et al.  Prostaglandin influence on pulmonary intravascular leukocytic aggregation during cardiopulmonary bypass. , 1977, The Journal of thoracic and cardiovascular surgery.

[124]  G. Noon,et al.  Clinical experience with the Teflo disposable membrane oxygenator. , 1976, The Annals of thoracic surgery.

[125]  S. Shapiro,et al.  ABO BLOOD TYPES IN CONGENITAL HEART-DISEASE , 1975, The Lancet.

[126]  M. Debakey,et al.  Membrane vs Bubble Oxygenator: Clinical Comparsion , 1975, Annals of surgery.

[127]  J. Wilson.  The pulmonary cellular and subcellular alterations of extracorporeal circulation. , 1974, The Surgical clinics of North America.

[128]  N. Ratliff,et al.  Pulmonary injury secondary to extracorporeal circulation. An ultrastructural study. , 1973, The Journal of thoracic and cardiovascular surgery.

[129]  I. Gigli,et al.  The complement system of man. 3. , 1972, The New England journal of medicine.

[130]  Karp Rb,et al.  Changes in serum complement and immunoglobulins following cardiopulmonary bypass. , 1972 .

[131]  A. Janoff.  Mediators of tissue damage in leukocyte lysosomes. X. Further studies on human granulocyte elastase. , 1970, Laboratory investigation; a journal of technical methods and pathology.

[132]  H. Müller-Eberhard,et al.  THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO , 1965, The Journal of experimental medicine.

[133]  F. Spencer,et al.  INCREASED PULMONARY VASCULAR RESISTANCE FOLLOWING PROLONGED PUMP OXYGENATION. , 1965, The Journal of thoracic and cardiovascular surgery.

[134]  A. Galloway,et al.  Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. , 1995, The Annals of thoracic surgery.

[135]  M. Elliott,et al.  Cardiopulmonary bypass in neonates, infants and young children , 1994 .

[136]  P. Menasché,et al.  A potential mechanism of vasodilation after warm heart surgery. The temperature-dependent release of cytokines. , 1994, The Journal of thoracic and cardiovascular surgery.

[137]  W. Baumgartner,et al.  Inhibition of neutrophil adhesion during cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.

[138]  R. Colman,et al.  Upregulation of Mac-1 surface expression on neutrophils during simulated extracorporeal circulation. , 1993, The Journal of laboratory and clinical medicine.

[139]  J. Levy.  4 – Complement and Contact Activation , 1992 .

[140]  W. van Oeveren,et al.  The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[141]  C W Smith,et al.  Effect of venous shear stress on CD18-mediated neutrophil adhesion to cultured endothelium. , 1990, Blood.

[142]  C. Dinarello,et al.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.

[143]  R. Colman,et al.  Platelet and neutrophil activation in cardiopulmonary bypass. , 1990, The Annals of thoracic surgery.

[144]  P. Venge,et al.  Inflammatory system activation during cardiopulmonary bypass as an indicator of biocompatibility: a randomized comparison of bubble and membrane oxygenators. , 1990, Scandinavian journal of thoracic and cardiovascular surgery.

[145]  P. Venge,et al.  Activation of inflammatory systems during cardiopulmonary bypass. , 1988, Scandinavian journal of thoracic and cardiovascular surgery.

[146]  M. Hemler,et al.  Adhesive protein receptors on hematopoietic cells. , 1988, Immunology today.

[147]  U. Kucich,et al.  Human neutrophil degranulation during extracorporeal circulation , 1987 .

[148]  L. W. Andersen,et al.  Presence of circulating endotoxins during cardiac operations. , 1987, The Journal of thoracic and cardiovascular surgery.

[149]  Ford-Hutchinson Aw.  Leukotrienes: their formation and role as inflammatory mediators. , 1985, Federation proceedings.

[150]  P. Curreri,et al.  Platelet and neutrophil sequestration after fragment D-induced respiratory distress. , 1982, Circulatory shock.

[151]  P. Ward,et al.  Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. , 1982, The American journal of pathology.

[152]  Haslam Pl,et al.  Complement activation during cardiopulmonary bypass , 1980 .

[153]  F. Mckenzie,et al.  The membrane lung in routine bloodless open heart surgery. , 1977, Advances in experimental medicine and biology.

[154]  H. Gewurz,et al.  Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement. , 1975, Journal of immunology.

[155]  A. Janoff.  Neutrophil proteases in inflammation. , 1972, Annual review of medicine.